HealthCare Global Enterprises Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company’s Board of Directors also approved a further investment of up to INR 16 Crore in its wholly-owned subsidiary, HCG Rajkot Hospitals LLP. These updates reflect the company’s ongoing operational performance and strategic expansion plans.
HealthCare Global Enterprises Reports Q1 FY27 Results, Approves Subsidiary Investment
HealthCare Global Enterprises Limited (HCG) has disclosed its unaudited financial results for the first quarter of the fiscal year 2027, ending on June 30, 2026. The announcement, made on August 06, 2026, details the company’s performance and key strategic decisions made by its Board of Directors.
Financial Performance Highlights
The reported results include both standalone and consolidated financial figures. For the quarter ended June 30, 2026, the company presented its unaudited financial statements. The key financial outcomes are detailed within the accompanying statements.
Strategic Investment in Subsidiary
In addition to the financial results, the Board of Directors approved a significant strategic move: a further investment of up to INR 16 Crore in HCG Rajkot Hospitals LLP. This subsidiary is wholly owned by HealthCare Global Enterprises Limited. This investment signals a commitment to expanding the company’s presence and capabilities within its subsidiary operations.
Cost Audit Re-appointment
The Board also approved the re-appointment of M/s. Rao Murthy & Associates as the company’s Cost Auditor for the financial year 2026-27, further solidifying the company’s governance and financial oversight processes.
Board Meeting Details
The Board of Directors’ meeting commenced at 11:30 a.m. and concluded at 06:50 p.m. on August 06, 2026. The disclosed financial results are made available on the company’s website, hcgoncology.com, for public access.
Source: BSE
